[{"address1": "401 Professional Drive", "address2": "Suite 260", "city": "Gaithersburg", "state": "MD", "zip": "20879", "country": "United States", "phone": "240 403 4212", "website": "https://www.shuttlepharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mira  Jung Ph.D.", "age": 75, "title": "Co-Founder & Chief Scientific Officer for Biology", "yearBorn": 1949, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy J. Lorber CPA", "age": 65, "title": "Chief Financial Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 177511, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tyvin A. Rich M.D.", "age": 76, "title": "Chief Clinical Officer & Chief Medical Officer", "yearBorn": 1948, "fiscalYear": 2024, "totalPay": 218000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael P. Vander Hoek", "age": 64, "title": "Vice President for Operations and Regulatory", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 506634, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher Robert Cooper BBA, M.B.A., MBA", "age": 54, "title": "Interim Chief Executive Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Milton  Brown CSC, M.D., Ph.D.", "age": 59, "title": "Co-Founder", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.31, "open": 2.3, "dayLow": 2.22, "dayHigh": 2.41, "regularMarketPreviousClose": 2.31, "regularMarketOpen": 2.3, "regularMarketDayLow": 2.22, "regularMarketDayHigh": 2.41, "payoutRatio": 0.0, "volume": 46658, "regularMarketVolume": 46658, "averageVolume": 220728, "averageVolume10days": 494710, "averageDailyVolume10Day": 494710, "bid": 2.27, "ask": 2.41, "bidSize": 1, "askSize": 1, "marketCap": 2484193, "fiftyTwoWeekLow": 2.22, "fiftyTwoWeekHigh": 25.25, "allTimeHigh": 25252.0, "allTimeLow": 2.22, "fiftyDayAverage": 3.53786, "twoHundredDayAverage": 6.42543, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2292309, "profitMargins": 0.0, "floatShares": 1477972, "sharesOutstanding": 1070773, "sharesShort": 135248, "sharesShortPriorMonth": 54046, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.1263, "heldPercentInsiders": 0.03279, "heldPercentInstitutions": 0.06245, "shortRatio": 0.46, "shortPercentOfFloat": 0.1296, "impliedSharesOutstanding": 1070773, "bookValue": 1.128, "priceToBook": 2.0567374, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -10705243, "trailingEps": -46.34, "lastSplitFactor": "1:25", "lastSplitDate": 1750032000, "enterpriseToEbitda": -0.21, "52WeekChange": -0.90032226, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 2.32, "recommendationKey": "none", "totalCash": 2094643, "totalCashPerShare": 1.306, "ebitda": -10902884, "totalDebt": 667331, "quickRatio": 1.066, "currentRatio": 1.662, "debtToEquity": 47.866, "returnOnAssets": -3.2330499, "returnOnEquity": -271.76184, "freeCashflow": -7386604, "operatingCashflow": -11198795, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SHPH", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Shuttle Pharmaceuticals Holding", "longName": "Shuttle Pharmaceuticals Holdings, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": 0.4329, "regularMarketPrice": 2.32, "corporateActions": [], "postMarketTime": 1763157644, "regularMarketTime": 1763154000, "exchange": "NCM", "messageBoardId": "finmb_319499082", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "cryptoTradeable": false, "postMarketChangePercent": -3.0172386, "postMarketPrice": 2.25, "postMarketChange": -0.06999993, "regularMarketChange": 0.00999999, "regularMarketDayRange": "2.22 - 2.41", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 220728, "fiftyTwoWeekLowChange": 0.099999905, "fiftyTwoWeekLowChangePercent": 0.045045003, "fiftyTwoWeekRange": "2.22 - 25.25", "fiftyTwoWeekHighChange": -22.93, "fiftyTwoWeekHighChangePercent": -0.90811884, "fiftyTwoWeekChangePercent": -90.03223, "epsTrailingTwelveMonths": -46.34, "fiftyDayAverageChange": -1.21786, "fiftyDayAverageChangePercent": -0.34423634, "twoHundredDayAverageChange": -4.1054296, "twoHundredDayAverageChangePercent": -0.6389346, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1661952600000, "displayName": "Shuttle Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]